Literature DB >> 520400

Multicompartment pharmacokinetics of netilmicin.

M Wenk, P Spring, S Vozeh, F Follath.   

Abstract

The pharmacokinetics of a single dose of netilmicin (NM) was studied in 6 healthy volunteers. Elimination of the drug was followed in serum and urine for 24 h and 72 h, respectively. NM concentrations were measured with a modified radioenzymatic assay. A three compartment open model was employed to calculate the pharmacokinetic parameters. Following the rapid initial distribution, biphasic elimination with half lives of 1.99 (t 1/2 beta) and 36.89 h (t 1/2 gamma) was demonstrated. Measurable amounts of NM were excreted in the urine for up to 72 h. The volume of distribution at steady-state (Vdss) of 0.68 l/kg was 3 to 4 times larger than previously reported for this antibiotic. NM plasma clearance was 91 ml/min and the renal clearance was 67 ml/min. The data indicate that on repetitive dosing the amount of drug in the body would be considerably underestimated if the prolonged terminal elimination phase were not taken into account. During prolonged treatment, accumulation of NM in renal and other tissues is likely to occur, as has been described for other aminoglycosides. The possible consequences of this pharmacokinetic behaviour are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 520400     DOI: 10.1007/BF00605631

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  15 in total

1.  Gentamicin gradient patterns and morphological changes in human kidneys.

Authors:  F C Luft; M N Yum; P D Walker; S A Kleit
Journal:  Nephron       Date:  1977       Impact factor: 2.847

2.  Concentrations of gentamicin and amikacin in human kidneys.

Authors:  C Q Edwards; C R Smith; K L Baughman; J F Rogers; P S Lietman
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

3.  Comparative pharmacokinetics of tobramycin and gentamicin.

Authors:  C Regamey; R C Gordon; W M Kirby
Journal:  Clin Pharmacol Ther       Date:  1973 May-Jun       Impact factor: 6.875

4.  The acetyltransferase enzyme method for the assay of serum gentamicon concentrations and a comparison with other methods.

Authors:  J M Broughall; D S Reeves
Journal:  J Clin Pathol       Date:  1975-02       Impact factor: 3.411

5.  Prescribing aids for gentamicin.

Authors:  G E Mawer; R Ahmad; S M Dobbs; J G McGough; S B Lucas; J A Tooth
Journal:  Br J Clin Pharmacol       Date:  1974-02       Impact factor: 4.335

6.  In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics.

Authors:  S A Kabins; C Nathan; S Cohen
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

7.  Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms.

Authors:  J J Rahal; M S Simberkoff; K Kagan; N H Moldover
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

8.  Kinetics of netilmicin in man.

Authors:  J C Pechere; R Dugal; M M Pechere
Journal:  Clin Pharmacol Ther       Date:  1978-06       Impact factor: 6.875

9.  Comparative nephrotoxicity of aminoglycoside antibiotics in rats.

Authors:  F C Luft; R Bloch; R S Sloan; M N Yum; R Costello; D R Maxwell
Journal:  J Infect Dis       Date:  1978-10       Impact factor: 5.226

10.  [Delayed elimination of aminoglycoside antibiotics: importance for clinical use].

Authors:  S Vozeh; M Wenk; P Spring; F Follath
Journal:  Schweiz Med Wochenschr       Date:  1979-12-01
View more
  19 in total

Review 1.  Systems dynamics in clinical pharmacokinetics. An introduction.

Authors:  J M van Rossum; J E de Bie
Journal:  Clin Pharmacokinet       Date:  1989-07       Impact factor: 6.447

Review 2.  Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy.

Authors:  Federico Pea; Pierluigi Viale; Federica Pavan; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

3.  Renal Clearance in Newborns and Infants: Predictive Performance of Population-Based Modeling for Drug Development.

Authors:  Jian Wang; Shaun S Kumar; Catherine M Sherwin; Robert Ward; Gerri Baer; Gilbert J Burckart; Yaning Wang; Lynne P Yao
Journal:  Clin Pharmacol Ther       Date:  2019-02-10       Impact factor: 6.875

4.  Dosing Recommendations for Continuous Venovenous Hemodiafiltration with AN69 Filter Membranes and Prismaflex Dialyzers.

Authors:  Eugenia Yeh; Glen Brown
Journal:  Can J Hosp Pharm       Date:  2009-11

5.  Homogeneous enzyme immunoassay for netilmicin.

Authors:  M Wenk; R Hemmann; F Follath
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

6.  Biological variability of multiple dose pharmacokinetics of netilmicin in man.

Authors:  J Blaser; H Rieder; P Niederer; R Lüthy
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Predicted tissue accumulation of netilmicin in patients.

Authors:  D J Edwards; A Mangione; T J Cumbo; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

8.  Pharmacokinetics of netilmicin in children with and without cystic fibrosis.

Authors:  H Michalsen; T Bergan
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

Review 9.  Nonparametric meta-analysis of published data on kidney-function dependence of pharmacokinetic parameters for the aminoglycoside netilmicin.

Authors:  F Keller; K Erdmann; M Giehl; P Buettner
Journal:  Clin Pharmacokinet       Date:  1993-07       Impact factor: 6.447

10.  Pharmacokinetic study of sisomicin in humans.

Authors:  M Chung; J J Schrogie; S Symchowicz
Journal:  J Pharmacokinet Biopharm       Date:  1981-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.